INVO Fertility (IVF) Income towards Parent Company (2011 - 2026)
INVO Fertility (IVF) posted quarterly Income towards Parent Company of -$1.7 million for Q1 2026, up 89.02% year-over-year from -$924697.4 in Q1 2025, and down 422.92% quarter-over-quarter from $541247.0 in Q4 2025.
INVO Fertility (IVF) Income towards Parent Company (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Income towards Parent Company for 16 consecutive years, with -$1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company rose 89.02% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$16.7 million (up 29.17% YoY), while the FY2025 annual figure was -$15.9 million, down 72.67% from the prior year.
- Income towards Parent Company declined to -$1.7 million in Q1 2026 per IVF's latest filing, from $541247.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $541247.0 in Q4 2025 and bottomed at -$15.9 million in Q1 2025.
- Historically, Income towards Parent Company has averaged -$3.6 million across 5 years, with a median of -$2.2 million in 2024.
- Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 2818.28% — and 2025, when it soared 114.46%.
- INVO Fertility's Income towards Parent Company stood at -$2.8 million in 2022, then rose by 28.98% to -$2.0 million in 2023, then slumped by 90.44% to -$3.7 million in 2024, then jumped by 114.46% to $541247.0 in 2025, then slumped by 422.92% to -$1.7 million in 2026.
- Business Quant data shows IVF's Income towards Parent Company at -$1.7 million in Q1 2026, $541247.0 in Q4 2025, and -$14.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.75 Mn |
| Dec 31, 2025 | 541,247.00 |
| Sep 30, 2025 | -14.92 Mn |
| Jun 30, 2025 | -541,247.00 |
| Mar 31, 2025 | -15.91 Mn |
| Dec 31, 2024 | -3.74 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | -1.97 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -2.80 Mn |
| Mar 31, 2022 | -2.95 Mn |
| Dec 31, 2021 | 101,782.00 |
| Sep 30, 2021 | -2.48 Mn |
| Jun 30, 2021 | -1.82 Mn |